Zobrazeno 1 - 10 of 288 pro vyhledávání: '"Robert B. Jaffe"'
1
Akademický článek
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects
Autor: Philippe N. Duchateau, Irina Movsesyan, Shizuya Yamashita, Naohiko Sakai, Ken-Ichi Hirano, Samantha A. Schoenhaus, Patricia M. O'Connor-Kearns, Susan J. Spencer, Robert B. Jaffe, Rita F. Redberg, Brian Y. Ishida, Yugi Matsuzawa, John P. Kane, Mary J. Malloy
Publikováno v: Journal of Lipid Research, Vol 41, Iss 8, Pp 1231-1236 (2000)
Apolipoprotein L is a newly recognized component of human plasma lipoproteins. Mainly associated with apoA-I-containing lipoproteins, it is a marker of distinct HDL subpopulations. In an effort to gain inference as to its as yet unknown function, we
Externí odkaz: https://doaj.org/article/3804106866a1497998ae67281827f9eb
Zobrazit plný text záznamu
2
Data from Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Autor: Anil K. Sood, Robert B. Jaffe, Robert L. Coleman, Nicholas B. Jennings, Alpa M. Nick, Tao Liu, Yu Kang, Archana S. Nagaraja, Rajesha Rupaimoole, Michael McGuire, Yunjie Sun, Xiao-Yun Yang, Heather J. Dalton, Rebecca A. Previs, Limin Hu, Wei Hu, Jie Huang
Delta-like ligand 4 (Dll4), one of the Notch ligands, is overexpressed in ovarian cancer, especially in tumors resistant to anti-VEGF therapy. Here, we examined the biologic effects of dual anti-Dll4 and anti-VEGF therapy in ovarian cancer models. Us
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209eec1cad563956fa84c6c7a5c8eea3
https://doi.org/10.1158/1535-7163.c.6536509
Zobrazit plný text záznamu
3
Supplementary Figures 1-6 from Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Autor: Anil K. Sood, Robert B. Jaffe, Robert L. Coleman, Nicholas B. Jennings, Alpa M. Nick, Tao Liu, Yu Kang, Archana S. Nagaraja, Rajesha Rupaimoole, Michael McGuire, Yunjie Sun, Xiao-Yun Yang, Heather J. Dalton, Rebecca A. Previs, Limin Hu, Wei Hu, Jie Huang
Supplementary Figure 1. Representative OVCAR3-inoculated mice after aflibercept, Dll4-Fc, and the combination. Supplementary Figure 2. In vivo study of Dll4 blockade, aflibercept, and docetaxel, alone and in combinations, in A2780 and HeyA8 models. S
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0701b69b966c5a8ed5703d5610faf646
https://doi.org/10.1158/1535-7163.22500595
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje